Sorry, we do not have enough data to show an influence graph for this author.
AIM Zolmitriptan is a 5-HT receptor agonist (1B/1D). It is used in the acute treatment of migraine having low bioavailability about 40% orally due to hepatic first pass metabolism. The purpose of the present research was to formulate fast acting sublingual tablets of zolmitriptan. MATERIALS AND METHODS Sublingual tablets were prepared using ispaghula husk… (More)